Evidence map›Paper›PMID 28275689›Full record

ArticleCellular and molecular gastroenterology and hepatology2017

Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder.

Ruth Ann Luna, Numan Oezguen, Miriam Balderas, Alamelu Venkatachalam, Jessica K Runge, James Versalovic, Jeremy Veenstra-VanderWeele, George M Anderson, Tor Savidge, Kent C Williams

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03426826 (Dynamics of Gut Microbiomes in Autism Spectrum Disorder), which is not on this map. Cited by 164 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
164citing papers in PubMed, 13 pooled it
46.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03426826 phase1unknown statusnot on this mapstarted 2019, after this paper: background citation

Dynamics of Gut Microbiomes in Autism Spectrum Disorder (ASD) Symptoms

TypeinterventionalSponsorChildren's Hospital Los AngelesRan2019 to 2026Enrolled10ConditionsAutism Spectrum Disorder (ASD), Gastro-Intestinal DisorderArmsFMT versus placebo
3 · Its place in the literature

Who cites it

164 citing papers in PubMed, 13 syntheses or guidelines pooled it, 294 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Microbiota in Autism Spectrum Disorder: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  6. Pooled it
  7. Comparing the Gut Microbiome in Autism and Preclinical Models: A Systematic Review.Frontiers in cellular and infection microbiology · 2022
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. Article

104 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ruth Ann LunaTexas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas.
Numan OezguenTexas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas.
Miriam BalderasTexas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas.
Alamelu VenkatachalamTexas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas.
Jessica K RungeTexas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas.
James VersalovicTexas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas.
Jeremy Veenstra-VanderWeeleDepartment of Psychiatry, Columbia University, New York, New York.
George M AndersonYale Child Study Center, Yale University School of Medicine, New Haven, Connecticut; Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut.
Tor SavidgeTexas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas.
Kent C WilliamsDepartment of Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, Ohio.
Baylor College of Medicine · USColumbia University · USNationwide Children's Hospital · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Decoding Antibiotic-induced Susceptibility to Clostridium difficile InfectionU01AI124290 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BRITTON, ROBERT A, GAREY, KEVIN W · 2016 to 2020
$7.9M
The Human Microbiome in Pediatric Abdominal Pain and Intestinal InflammationUH3DK083990 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI VERSALOVIC, JAMES · 2010 to 2012
$3.3M
Neurobiological Signatures of Social Dysfunction and Repetitive BehaviorR01MH094604 · NIMH · VANDERBILT UNIVERSITY · PI VEENSTRA-VANDERWEELE, JEREMY · 2011 to 2015
$2.0M
Allosteric therapy of the Clostridium difficile toxinsR01AI100914 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SAVIDGE, TOR C. · 2012 to 2016
$1.9M
NCATS NIH HHS UL1 TR001863NIAID NIH HHS R01 AI100914NIAID NIH HHS U01 AI124290NIDDK NIH HHS P30 DK056338NIDDK NIH HHS UH3 DK083990NIMH NIH HHS R01 MH094604
6 · The paper itself

Abstract

BACKGROUND &

aimsEmerging data on the gut microbiome in autism spectrum disorder (ASD) suggest that altered host-microbe interactions may contribute to disease symptoms. Although gut microbial communities in children with ASD are reported to differ from individuals with neurotypical development, it is not known whether these bacteria induce pathogenic neuroimmune signals.

methodsBecause commensal clostridia interactions with the intestinal mucosa can regulate disease-associated cytokine and serotonergic pathways in animal models, we evaluated whether microbiome-neuroimmune profiles (from rectal biopsy specimens and blood) differed in ASD children with functional gastrointestinal disorders (ASD-FGID, n = 14) compared with neurotypical (NT) children with FGID (NT-FGID, n = 15) and without abdominal pain (NT, n = 6). Microbial 16S ribosomal DNA community signatures, cytokines, and serotonergic metabolites were quantified and correlated with gastrointestinal symptoms.

resultsA significant increase in several mucosa-associated Clostridiales was observed in ASD-FGID, whereas marked decreases in

conclusionsOur findings identify distinctive mucosal microbial signatures in ASD children with FGID that correlate with cytokine and tryptophan homeostasis. Future studies are needed to establish whether these disease-associated Clostridiales species confer early pathogenic signals in children with ASD and FGID.

Indexed as

5-HIAA, 5-hydroxyindoleacetic acid5-HT, serotoninASD, autism spectrum disorderFGID, functional gastrointestinal disorderGastrointestinal DisordersGI, gastrointestinalGM-CSF, granulocyte-macrophage colony-stimulating factorGROα, growth-related oncogene alphaIBS, irritable bowel syndromeIFN, interferonIL, interleukinIP, interferon gamma-induced proteinMCP-1, monocyte chemoattractant proteinMicrobiomeMicrobiome–Gut–Brain AxisMIP, macrophage inflammatory proteinMucosaNT, neurotypicalOTU, operational taxonomic unitQPGS-RIII, Questionnaire on Pediatric Gastrointestinal Symptoms-Rome IIISerotoninTNF, tumor necrosis factorVEGF, vascular endothelial growth factor

Identifiers

PMID28275689
PMCPMC5331780
OpenAlexW2559803799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.